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Mechanisms underlying cell-type-specific response
tomorphogens or signalingmolecules during embry-
onic development are poorly understood. To learn
how response to the liver-inductive Wnt2bb signal
is achieved, we identify an endoderm-enriched,
single transmembrane protein, epithelial-cell-adhe-
sion-molecule (EpCAM), as an endoderm-specific
Wnt derepressor in zebrafish. hi2151/epcammutants
exhibit defective liver development similar to prt/
wnt2bb mutants. EpCAM directly binds to Kremen1
and disrupts the Kremen1-Dickkopf2 (Dkk2) inter-
action, which prevents Kremen1-Dkk2-mediated
removal of Lipoprotein-receptor-related protein 6
(Lrp6) from the cell surface. These data lead to
a model in which EpCAM derepresses Lrp6 and
cooperates with Wnt ligand to activate Wnt signaling
through stabilizing membrane Lrp6 and allowing
Lrp6 clustering into active signalosomes. Thus,
EpCAM cell autonomously licenses and coopera-
tively activates Wnt2bb signaling in endodermal
cells. Our results identify EpCAM as the keymolecule
and its functional mechanism to confer endodermal
cells the competence to respond to the liver-induc-
tive Wnt2bb signal.
INTRODUCTION
The liver is an essential digestive organ originated from the endo-
derm. It carries out several critical functions including production
of bile, detoxification, glycogen storage, and regulation of blood
homeostasis. During embryonic development, liver is specified
and induced at a precise anterior-posterior position within the
endoderm (Zaret, 2008; Field et al., 2003). Several inductive
signals such as fibroblasts growth factor (Fgf), bone morphoge-
netic protein (Bmp), and Wnt from adjacent mesodermal tissues
have been implicated in liver development (Jung et al., 1999;
Deutsch et al., 2001; Calmont et al., 2006; Rossi et al., 2001;
Shin et al., 2007; Zhang et al., 2004; McLin et al., 2007; Ober
et al., 2006). Liver development is defective in zebrafish
prometheus (prt) mutant carrying a mutation in the canonical
Wnt-family gene wnt2bb, revealing a pivotal role of Wnt2bbDevelo(Ober et al., 2006). wnt2bb is expressed in restricted bilateral
domains of the lateral plate mesoderm (LPM) directly adjacent
to the hepatic endoderm, obtaining the spatial capability to regu-
late hepatic development. However, the cell-type-specific
competence issue, why and how do only specific cell types
obtain the competence to respond to a signaling molecule or
growth factor, remains one of the key questions in develop-
mental biology (Zaret, 2008; Zorn and Wells, 2009; Wandzioch
and Zaret, 2009; van Amerongen and Nusse, 2009). In the
context of liver development, although Wnt2bb has gained the
spatial capability to induce liver, there are a number of cell types
around the Wnt2bb-secreting mesoderm. Molecules and mech-
anisms that specifically allow endodermal cells to transduce the
Wnt2bb signal to become liver remain unknown.
EpCAM/Tacstd is a single transmembrane glycoprotein origi-
nally identified as a marker of epithelial-derived carcinoma. It
was proposed to be a homophilic cell-cell adhesion molecule
in early studies (Litvinov et al., 1994, 1997), and has recently
been implicated in proliferation, differentiation, cell migration,
and metastasis (Trzpis et al., 2007). Roles of EpCAM in embry-
onic development have only been reported in the deposition of
lateral line proneuromast and epithelial morphogenesis in
zebrafish mutant and morphant studies (Villablanca et al.,
2006; Slanchev et al., 2009). Although EpCAM has lately been
identified as a surfacemarker on human hepatic stem/progenitor
cells as well as newly derived hepatocytes (de Boer et al., 1999;
Schmelzer et al., 2006; Zhang et al., 2008b; Yoon et al., 2011), its
roles and functional mechanisms in liver development have not
been addressed.
Activation of canonical Wnt signaling is initiated by a receptor
complex formation betweenWnt ligand, a seven transmembrane
receptor Frizzled, and coreceptor LRP5/6. This receptor
complex then recruits the scaffolding protein Dishevelled, which
leads to aggregation as well as phosphorylation of LRP6, in turn
the recruitment of the Axin complex to the receptors. Conse-
quently, Axin-mediated b-catenin phosphorylation and degrada-
tion is prohibited, allowing accumulation and nuclear transloca-
tion of b-catenin to form complexes with TCF/LEF to activate
Wnt target gene expression (Clevers, 2006; MacDonald et al.,
2009). Canonical Wnt signaling can be modulated by the extra-
cellular protein Dkk and transmembrane protein Kremen. Dkk
interacts with Kremen and LRP6, forming a ternary complex to
mediate removal of LRP6 from the cell surface (Mao et al.,
2001, 2002; Davidson et al., 2002). This prevents formation of
LRP6 aggregates (referred to as ‘‘signalosomes’’), which is
a key step preceding LRP6 phosphorylation and activationpmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevier Inc. 543
Figure 1. Liver Development Is Impaired in
hi2151/epcam Zebrafish Mutant
(A) Western blotting on the embryonic lysates at
24 hpf using antibodies against the ICD of zebra-
fish EpCAM. a-Tubulin serves as a loading control.
(B) Except smaller otoliths, there is no obviously
visible phenotype in hi2151 mutant embryos at
52 hpf.
(C and D) Liver bud in hi2151mutants (D, 41/60) is
smaller than that in the wild-type (C, 55/56) at
52 hpf as observed under the Tg(gutGFP) trans-
genic background. L, liver; P, pancreas.
(E–G) In contrast to the wild-type (E, 50/50), liver
size is reduced in hi2151 mutants at 102 hpf
(F, 52/72), whereas injection of epcam mRNA
leads to enlarged liver (G, 45/59) as shown under
the Tg(lfabp:GFP) transgenic background.
(H–O) Expressions of hepatoblast specification
markers hhex (H, 32/35; and I, 29/40; arrowheads)
and prox1 (J, 36/37) (K, 28/37) at 28 hpf as well as
differentiation markers cp (L, 39/41) (M, 27/39) and
sePb (N, 31/34) (O, 30/38) at 52 hpf.
See also Figures S1, S2, S6, and Table S1.
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EpCAM Licenses Hepatic Development(Bilic et al., 2007; Pan et al., 2008; Liang et al., 2011). Concerning
the mechanism of Wnt2bb signal transduction during hepatic
development, additional factors remain to be identified.
In this study, the questions of cell-type-specific competence
and factors involved in the Wnt2bb-induced liver development
prompt us search for zebrafish mutants with liver phenotypes
similar to prt/wnt2bb mutants. We found that hi2151/epcam
mutants exhibited cell-autonomous defects in hepatic develop-
ment and the expression of epcam was enriched in the endo-
derm. Further biochemical analyses revealed that EpCAM
directly binds to Kremen1 and disrupts the Dkk2-Kremen1 inter-
action, which inhibits removal of Lrp6 from the cell surface and
allows Lrp6 clustering into active signalosomes. Thus, EpCAM
licenses and cooperatively activates the Wnt2bb-induced liver
development specifically in endodermal cells. Our results illus-
trate that EpCAM is the key molecule that confers on endo-
dermal cells the competence to respond to the liver-inductive




In hi2151/epcam zebrafish null mutant
(Figure 1A), in which a premature stop
codon has been introduced 42 base pairs
downstream of the translational initiation
site of epcam, there is no obviously visible
phenotype at 52 hr postfertilization
(hpf) except smaller otoliths (Amsterdam
et al., 2004; Slanchev et al., 2009)
(Figure 1B). However, we identified liver
phenotypes when the mutant line was
crossed into the Tg(gutGFP) transgenic
background expressing green fluores-
cent protein (GFP) throughout the devel-oping endoderm (Field et al., 2003). Liver tissue in hi2151
mutants formed a small protrusion and became remarkably
reduced at 52 hpf, whereas other endodermal tissues such as
pancreas and gut remained relatively normal (Figures 1C, 1D;
Table S1 available online). This aberrant liver development was
further confirmed at 72 hpf and 102 hpf under the Tg(lfabp:GFP)
background, a transgenic line with liver labeled with GFP
(Figures 1E, 1F, S1, and S2A–S2D). Ectopic expression of
EpCAM led to enlarged liver at 102 hpf (Figures 1A, 1G, and S1).
To determine at which stage defects in liver development can
first be observed in the mutant, expressions of hepatic specifi-
cation markers hhex and prox1 at 28 hpf as well as differentia-
tion markers ceruloplasmin (cp) and selenoproteinPb (sePb) at
52 hpf were analyzed. All four markers were reduced but
not completely missing (Figures 1H–1O), suggesting that the
hepatoblast expansion or maintenance is defective in hi2151
mutants. In contrast to the endodermal marker foxa3 and
pancreatic/intestinal markers, the transcriptional levels of 12
Figure 2. EpCAM Acts Downstream of Wnt2bb in Liver Development through Its Extracellular Domain
(A–E) At 102 hpf, liver phenotypes in hi2151mutants (B, 37/50) can not be rescued bywnt2bbmRNA (C, 33/46), whereas reduced liver size inwnt2bbmorphants
(D, 66/90) is rescued by epcam mRNA (E, 73/99) as shown under the Tg(lfabp:GFP) background.
(F–O) Expressions of hhex (F–J, arrowheads) at 28 hpf and cp (K–O) at 52 hpf in the hepatic endoderm.
(P–R) Antibody stainings illustrate the membrane enrichment of EpCAM on hepatocytes at 52 hpf (P), which is extensively colocalized with the membrane GFP
signal under the Tg(rasGFP) background (Q and R).
(S–U) Defective liver development inwnt2bbmorphants at 102 hpf (D, 66/90) is rescued by either epcam ECD-TM (S, 51/66) or epcam ECD (T, 51/75) mRNA, but
not rescued by epcam ICD mRNA (U, 72/78).
See also Figures S1, S3, and Table S1.
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EpCAM Licenses Hepatic Developmenthepatic genes were all reduced in the sorted endodermal cells
of hi2151 mutants (Figure S2P), further confirming the require-
ment of EpCAM for the transcriptional profile of hepatic devel-
opment. The ratio of mitotic active cells in the mutant liver at
72 hpf turned out to be similar to that of control embryos
(Figures S2C–S2O), which indicates unaffected hepatocyte
proliferation in hi2151 mutants. Phenotype specificities in
mutantswere further confirmedby an antisensemorpholino oligo
specifically against epcam (epcamMO) (Villablanca et al.,
2006) (Figures S2Q–S2V). Defects in hepatic development in
hi2151/epcammutants nearly phenocopied those in prt/wnt2bb
mutants (Ober et al., 2006), implying functional connections
between EpCAM and Wnt2bb.
EpCAM Cell Autonomously Modulates Wnt2bb-Induced
Hepatic Development through Its Extracellular Domain
To investigate whether EpCAMandWnt2bb are functionally con-
nected in liver development, rescue analyses were performed.
Under the Tg(lfabp:GFP) background, injection of wnt2bb
mRNA could not rescue impaired liver development in hi2151
mutants (Figures 2A–2C). On the contrary, defective liver devel-
opment in wnt2bb morphants could be rescued by the coinjec-
tion of epcam mRNA (Figures 2D and 2E). Similar results were
obtained when expressions of hhex and cp were examined
(Figures 2F–2O). These data indicate that EpCAMmay act down-
stream of Wnt2bb in liver development.
Zebrafish EpCAM is a single transmembrane protein
(Villablanca et al., 2006), which is enriched on the plasma
membrane of hepatocytes at 52 hpf (Figures 2P–2R). To deter-
mine key functional domains pivotal for hepatic development,
cDNAs encoding extracellular domain (ECD), extracellular plus
transmembrane domain (ECD-TM), or intracellular domainDevelo(ICD) of EpCAM were constructed. Impaired liver development
in hi2151 mutants as well as in wnt2bb morphants could be
rescued by either full-length epcam, or epcam ECD-TM, or
epcam ECD mRNA, but not by epcam ICD mRNA (Figures
2D, 2E, 2S–2U, and S3A–S3F), suggesting that the ECD
undertakes entire functions of the full-length EpCAM in liver
development.
At the 14-somite stage before the emergence of hepatoblast,
expression of epcam was only detected in some epithelial
tissues such as otic vesicles and lateral line primordia, but not
in the endoderm (Figures 3A–3C). During hepatoblast develop-
ment at 24 hpf, besides these epithelial tissues distant from
the Wnt2bb-secreting mesoderm, epcam was also enriched in
the endoderm (Figures 3D–3F and S4A–S4D). Its expression
in the endoderm per se implies that EpCAM regulates hepatic
development cell autonomously, which was further confirmed
by mosaic analyses. After transplantation of rhodamine-labeled
Tg(lfabp:GFP) cells into hi2151 mutant embryos under the
Tg(lfabp:GFP) background, only wild-type cells massively
contributing to the hepatic endoderm were able to rescue
defective liver development in mutant acceptors (Figures
3G–3I). Wild-type donor cells contributing to the LPM around
the hepatic endoderm were unable to rescue the reduced liver
size in hi2151 mutants (Figures 3J–3L). In contrast to the wild-
type to wild-type transplantations in which donor cells could
contribute to part of the acceptor liver (Figures 3M–3O), donor
cells from rhodamine-labeled hi2151 mutant embryos failed to
contribute to the liver of wild-type acceptors (Figures 3P–3R).
These results demonstrate that EpCAM is cell autonomously
required for hepatic development.
Expression of epcam in the endoderm at 24 hpf persisted in
wnt2bbmorphants (Figures 3S and 3T), which excludes EpCAMpmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevier Inc. 545
Figure 3. EpCAM Is Enriched in the Endoderm and Cell Autonomously Modulates Wnt2bb-Induced Hepatic Development
(A–F) Double fluorescent in situ hybridizations (FISH) of epcam and foxa3 at the 14-somite stage (A–C) and 24 hpf (D–F). In the endoderm, note that epcam is not
detected at the 14-somite stage, but enriched at 24 hpf (arrowheads). foxa3 is an endodermal marker.
(G–R) Mosaic analyses using embryos injected with rhodamine-dextran as donors. Only wild-type donor cells massively contributing to the hepatic endoderm
(G–I, n = 5), but not those contributing to the surrounding LPM (J–L, n = 8), are able to rescue the reduced liver size in hi2151mutant acceptors. Transplantedwild-
type donor cells (M–O, n = 8), but not hi2151mutant donor cells (P–R, n = 10), are able to obviously contribute to the liver of wild-type acceptors. Tg(lfabp:GFP)
transgenic background is applied in all the donors and acceptors. Transplanted embryos are imaged at 60 hpf.
(S and T) As shown by FISH, expression of epcam in the endoderm at 24 hpf (S, 51/51, arrowhead) remains in wnt2bb morphants (T, 48/48, arrowhead).
See also Figure S4 and Table S1.
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EpCAM Licenses Hepatic Developmentas a transcriptional downstream factor of Wnt2bb. Injection of
epcam mRNA rescued defective liver development caused by
wnt2bbMO (Figures 2D and 2E), but could not rescue liver
phenotypes caused by treatments of XAV939 (Figures S3G–
S3I), a stimulator of b-catenin degradation (Huang et al., 2009).
These findings support that EpCAM positively regulates liver
development, most probably at the level of plasma membrane,
through modulating Wnt2bb signaling.
EpCAM Directly Binds to Kremen1 and Disrupts
the Kremen1-Dkk2 Interaction
To explore the mechanism through which EpCAM modulates
Wnt2bb signaling, we tested the direct physical interactions
between EpCAM and several canonical Wnt components.
HA-tagged Kremen1 (Kremen1-HA), but not Wnt2bb-HA or
Lrp6-HA, coimmunoprecipitated with Myc-tagged EpCAM
(EpCAM-Myc) from HEK293T cells (Figure 4A). Kremen1-HA,
but not Wnt2bb-HA or an irrelevant single transmembrane
protein Bmpr1ba-HA, was specifically pulled down by recombi-
nant GST-EpCAM fusion protein (Figure 4B), indicating the
direct interaction between EpCAM and Kremen1. Expression
of kremen1 was detected in endodermal cells at 24 hpf (Figures
S5A–S5D), and the interaction between EpCAM and Kremen1
was confirmed by their coimmunoprecipitations in zebrafish
embryos (Figure 4C). Among Dkks in zebrafish, neither dkk1a
nor dkk1b exhibited expression in or around the liver-forming
area at 24 hpf (Figures 4D and 4E). Only dkk2 was present in
the bilateral LPM domains neighboring the hepatic endoderm
at this stage (Figures 4F and S4D), obtaining the spatial capa-
bility to regulate hepatic development. Injection of dkk2 or
kremen1 mRNA led to reduced liver size, which could be
rescued by epcam mRNA (Figures 4G–4K), confirming the546 Developmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevierrepressive roles of Dkk2 and Kremen1 in liver development.
Because both EpCAM and Dkk bind to Kremen1, we then
examined the relationship between EpCAM-Kremen1 and
Dkk-Kremen1 interactions. The amount of Flag-tagged Dkk2
(Dkk2-Flag) coimmunoprecipitated with Kremen1-HA became
reduced by the increased addition of EpCAM-Myc (Figure 4M),
and vice versa (Figure 4N), suggesting that EpCAM and Dkk2
compete for the binding to Kremen1, and EpCAM will disrupt
the Kremen1-Dkk2 interaction. The functional significance of
this competition was substantiated by the rescued liver
phenotypes in hi2151 mutant embryos injected with dkk2MO
(Figure 4L).
EpCAM Reduces the Membrane Lrp6 Turnover, Allows
Lrp6 Clustering into Active Signalosomes, and
Cooperatively Activates Wnt Signaling
Because the Kremen1-Dkk2-Lrp6 complex mediates removal of
Lrp6 from the cell surface, we investigated whether disruption of
the Kremen1-Dkk2 interaction by EpCAM leads to stabilization
of Lrp6-Myc on the plasma membrane. After incubation with
Dkk2 conditioned medium (CM) or control CM, we labeled all
proteins on the cell surface with biotin. Along with increased
amounts of EpCAM-HA, the level of biotinylated, membrane
Lrp6-Myc became elevated (Figure 5A). To study the effect of
EpCAM on the turnover rate of Lrp6 on the plasma membrane,
we biotinylated cell surface proteins and performed pulse-chase
experiments (Seme¨nov et al., 2008). In the presence of Kremen1,
the extent and dynamics of membrane Lrp6-Myc turnover
became more rapid in cells incubated with Dkk2 CM than with
control CM (Figure 5B). EpCAM could rescue this rapid Lrp6-
Myc turnover caused by Dkk2 and Kremen1, and this rescue
effect is obvious only if Dkk2 is present (Figure 5B). All theseInc.
Figure 4. EpCAM Directly Binds to Kremen1 and Disrupts the Kremen1-Dkk2 Interaction
(A) EpCAM-Myc and Kremen1-HA mutually coimmunoprecipitated from HEK293T cells, negatively controlled by Wnt2bb-HA and Lrp6-HA. IP, immunopre-
cipitation; IB, immunoblotting.
(B) Kremen1-HA expressed in HEK293T cells is specifically pulled down by a GST-EpCAM fusion protein, but not by GST fused to an irrelevant nuclear protein
Geminin (GST-Gem). Bmpr1ba-HA and Wnt2bb-HA expressed in HEK293T cells are applied as negative controls. Quantities of GST-Gem and GST-EpCAM
recombinant proteins used in the pull-down assays were exhibited.
(C) Controlled by preimmune serum, endogenous EpCAM in the embryonic lysate at 24 hpf coimmunoprecipitates with antibodies against Kremen1.
(D–F) Expressions of dkk1a (D, 24/25), dkk1b (E, 26/29), and dkk2 (F, 12/15) at 24 hpf. Note that only dkk2 is present in the bilateral LPM domains adjacent to the
hepatic endoderm (arrowheads).
(G–L) Under the Tg(lfabp:GFP) background at 102 hpf, defects in liver development caused by dkk2mRNA (H, 44/73) or kremen1mRNA (J, 47/87) are rescued by
epcam mRNA (I, 53/64) and (K, 99/135). Reduced liver size in hi2151 mutants is rescued by dkk2MO (L, 50/76).
(M) In HEK293T cells, along with increases in the amount of epcam-Myc plasmid used for transfection (mg), the levels of coimmunoprecipitated Dkk2-Flag with
Kremen1-HA get reduced.
(N) In HEK293T cells, along with increases in the amount of dkk2-Flag plasmid used for transfection (mg), the levels of coimmunoprecipitated EpCAM-Myc with
Kremen1-HA get reduced.
See also Figures S1, S5, and Table S1.
Developmental Cell
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on the cell surface.
We next investigated whether this stabilization of Lrp6 on
the cell surface by EpCAM promotes aggregation of active
Lrp6-signalosomes. Sucrose density-gradient centrifugations
were applied to analyze endogenous LRP6 aggregates.
Significantly more LRP6 and more phosphorylated, active form
of LRP6 were detected in high molecular weight fractions
when EpCAM was overexpressed, similar to the effects of
Wnt3a stimulation (Figure 5C). By confocal microscopy, punc-Develotate signals containing endogenous phosphorylated LRP6 at
the plasma membrane and cytosol confirmed the increases in
active LRP6 aggregates when cells overexpressed EpCAM or
Wnt3a (Figures 5D–5F). These results illustrate that EpCAM
promotes formation of active Lrp6-signalosomes similar to Wnt
ligand stimulations.
To further determine the effects of EpCAM on Wnt signaling,
TOP-FLASH luciferase reporter assays normalized by Renilla
luciferase were performed. The attenuated TOP-FLASH activi-
ties by Kremen1 and Dkk2 were derepressed by the presencepmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevier Inc. 547
Figure 5. EpCAM Reduces the Membrane Lrp6 Turnover and Promotes Lrp6 Clustering into Active Signalosomes
(A) In HEK293T cells, along with increases in the amount of epcam-HA plasmid used for transfection (mg), the levels of biotinylated Lrp6-Myc on the plasma
membrane become increased.
(B) Pulse-chase experiments. Cell surface proteins of transfected HEK293T cells were biotinylated first, and the cells were incubated for the indicated period of
time with control or Dkk2 conditioned medium (CM). The levels of biotinylated membrane Lrp6-Myc were analyzed, controlled by the levels of membrane
Bmpr1ba-HA.
(C) In sucrose density-gradient centrifugations, more LRP6 as well as active Thr1493-phosphorylated LRP6 (p1493-LRP6) is detected in high molecular weight
fractions when EpCAM is overexpressed, similar to the effects of mWnt3a transfection or CM stimulation. Fractions 1 to 12, from high to low molecular weight.
mWnt3a, mouse Wnt3a.
(D–F) In HEK293T cells, punctate signals are detected by antibodies against p1493-LRP6. Plasma membranes of cells in (D) and (F) are labeled by Bmpr1ba-HA,
whereas those in (E) are labeled by EpCAM-Myc. DAPI labels the nuclei.
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EpCAM Licenses Hepatic Developmentof EpCAM (Figure 6A). Expression of myca, an endogenous
hepatic Wnt target gene (Shin et al., 2011), became reduced
at 28 hpf in hi2151 mutants, which could be rescued by the
injection of epcam mRNA (Figures 6B-6D). This in vivo result
further bolsters the role of EpCAM in Wnt/b-catenin signaling.
In sucrose density-gradient centrifugations, if cells were trans-
fected with EpCAM and Wnt3a alone or together at much lower
concentrations (one-tenth of concentrations used in Figure 5C),
EpCAM and Wnt ligand was demonstrated to be functional
cooperatively to allow formation of LRP6-signalosomes (Fig-
ure 6E). This cooperative effect of EpCAM with Wnt ligand in
particular with Wnt2bb was further confirmed by TOP-FLASH
luciferase reporter assays. HEK293T is an EpCAM deficient
cell line (Figure 6F) (Maetzel et al., 2009), in which a strong Wnt
ligand like Wnt1 could robustly activate the reporter activities.
Although Wnt2bb alone appeared to be a weak ligand, it could
efficiently activate the reporter together with EpCAM (Figure 6F).
These data indicate that EpCAM andWnt2bb cooperatively acti-
vate Wnt signaling.
Taken together, all these results demonstrate that EpCAM
directly binds to Kremen1 and disrupts the interaction between
Dkk2 and Kremen1, which stabilizes Lrp6 on the cell surface,
allows formation of active Lrp6-signalosomes, thus derepress-
ing and cooperatively activating Wnt signaling.548 Developmental Cell 24, 543–553, March 11, 2013 ª2013 ElsevierLrp6 Mediates the Roles of EpCAM and Wnt2bb
in Hepatic Development
Our data above suggest that EpCAM stabilizes Lrp6 on the
plasma membrane and allows formation of Lrp6-signalosomes.
Therefore, defects in hepatic development in hi2151/epcam
mutants should be due to insufficient Lrp6 on the cell surface
as well as insufficient formation of Lrp6-signalosomes. To prove
this biological significance of Lrp6 in liver development, extra
Lrp6was supplemented in hi2151mutants orwnt2bbmorphants
and the consequent phenotypes were analyzed. Under the
Tg(lfabp:GFP) background, impaired liver development in
hi2151 mutants or wnt2bb morphants could be rescued by lrp6
mRNA (Figures 7A–7E). In contrast, liver development was
defective in lrp6 morphants, which could not be rescued by
epcammRNA (Figures 7F and 7G). Similar results were obtained
when expressions of hhex and cp were examined (Figures 7H–
7U). These data indicate the critical roles of Lrp6 in transducing
the Wnt2bb signal and mediating the function of EpCAM in
hepatic development.
DISCUSSION
Both Lrp6 and Lrp5 are Wnt coreceptors. lrp5 and foxa3 double
fluorescent in situ hybridizations revealed that lrp5 is absent inInc.
Figure 6. EpCAM Derepresses Wnt Targets and Cooperatively Activates Wnt Signaling with Wnt Ligand
(A) TOP-FLASH firefly luciferase reporter assays normalized by Renilla luciferase activities. TOP-FLASH, Tcf-b-catenin reporter; m, mouse. Error bars
represent SD.
(B–D) In contrast to the wild-type control (B, 33/35), expression of myca in the liver-forming area is reduced in hi2151 mutants (C, 23/30), which is rescued by
epcam mRNA (D, 29/36).
(E) EpCAM and Wnt3a at low concentrations cooperatively allow formation of LRP6-signalosomes. The quantities of plasmids used for transfections are 10% of
those used in Figure 5C.
(F) TOP-FLASH luciferase reporter assays. HEK293T is an EpCAM deficient cell line. Note that Wnt2bb and EpCAM can cooperatively activate the reporter.
h, human. Error bars represent SD.
See also Table S1.
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EpCAM Licenses Hepatic Developmentthe endoderm at 24 hpf (Figure S4E), excluding any role of Lrp5 in
hepatic development. Using Tg(sox17:GFP) transgenic line in
which endodermal cells were labeled with GFP (Chung and
Stainier, 2008), injection of kremen1 mRNA and kremen1MO
respectively resulted in slightly increased and remarkably
reduced number of endodermal cells at the 14-somite stage
(Figures S5E–S5H). These results propose that before the posi-
tive role of Wnt2bb in hepatic development, Wnt signaling,
most likely operated by other Wnt ligands, negatively regulates
endoderm development in zebrafish. This is in line with impaired
liver and pancreas inductions caused by ectopicWnt signaling in
Xenopus (McLin et al., 2007). However, a heat shock overex-
pression of Kremen1 in the Tg(hsp70l:kremen1-GFP) transgenic
line at 18 hpf led to reduced liver size at 102 hpf (Figures S5I–
S5L), verifying Kremen1 as a negative regulator of Wnt signaling
at the time of Wnt2bb action. epcam is absent in the endoderm
at the 14-somite stage (Figures 3A–3C), suggesting that
EpCAM does not play any part in modulating Wnt signaling
during early endoderm development before the hepatic induc-
tion. Although dkk2MO did not result in obvious liver phenotypes,
it could rescue defective liver development in hi2151 mutants
(Figure 4L).
In human carcinoma cell lines, ICD of EPCAM is able to be
released, translocated into the nucleus, and directly interacts
with FHL2, a coactivator of b-catenin (Wei et al., 2003; Maetzel
et al., 2009). However, two evidences exclude this mechanism
in the context of liver development. First, nuclear translocations
of EPCAM ICD have only been observed in carcinoma samples,
never in normal biopsies (Maetzel et al., 2009). Second, our data
have demonstrated that the ECD, but not the ICD, of EpCAM
implements roles in liver development (Figures 2S–2U and
S3A–S3F).
hi2151/epcam mutants are homozygously viable and fertile
(Slanchev et al., 2009). However, this is not contradictory toDevelothe critical role of EpCAM in early hepatic development. Hepato-
cytes kept proliferating in hi2151 mutants, so that the liver
started to regenerate from 5 days postfertilization (dpf) on and
became relatively normal at 8 dpf (Figure S6), which is similar
to prt/wnt2bbmutants (Ober et al., 2006). The restoration of liver
inwnt2bbmutants can be explained due to complementation by
other Wnt ligands at later stages, whereas the restoration of liver
in hi2151 mutants can be explained by two possible reasons.
First, Wnt2bb is a weak Wnt ligand, it needs to act cooperatively
with EpCAM to allow formation of Lrp6-signalosomes and acti-
vate Wnt signaling (Figures 6E and 6F). Therefore, restoration
of liver in hi2151 mutants can be caused by other Wnt ligands
stronger than Wnt2bb, which is able to bypass the requirement
of EpCAM to activate Wnt signaling. Second, liver development
and regeneration may execute different regulatory mechanisms.
Restoration of liver in hi2151mutants can be due to activation of
liver regeneration program in which EpCAM and Wnt2bb may
not be required.
EpCAM has been reported as a surface marker on human
hepatic stem as well as progenitor cells, but absent on mature
hepatocytes (de Boer et al., 1999; Schmelzer et al., 2006; Zhang
et al., 2008b). During hepatocyte regeneration in chronic liver
injury, human liver stem/progenitor cells are characterized by
strong EpCAM expression. Along with process of hepatocellular
differentiation, expression of EpCAM shifts to an intermediate
level on newly derived hepatocytes and becomes negative on
mature hepatocytes (Yoon et al., 2011). In the meantime of
chronic liver injury and regeneration, macrophage engulfment
of hepatocyte debris induces Wnt3a expression, promoting
hepatic progenitor cell specification to hepatocytes (Boulter
et al., 2012). Although hepatocyte regeneration in chronic liver
injury and embryonic liver development represent different
scenarios of hepatocyte differentiation, the rationale and mech-
anism of Wnt-EpCAM actions could be the same or similar.pmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevier Inc. 549
Figure 7. Lrp6 Is Required to Mediate the Roles of EpCAM and Wnt2bb in Hepatic Development
(A–G) At 102 hpf, liver phenotypes in hi2151 mutants (B, 61/84) or wnt2bbmorphants (D, 90/104) are rescued by lrp6mRNA (C, 70/103; and E, 26/38), whereas
reduced liver size in lrp6 morphants (F, 101/137) cannot be rescued by epcam mRNA (G, 78/102) as shown under the Tg(lfabp:GFP) background.
(H–U) Expressions of hhex (H–N) at 28 hpf and cp (O–U) at 52 hpf in the hepatic endoderm.
(V) A model of determinations of cell type and position of hepatic development. Presence of EpCAM in the endoderm andWnt2bb at a specific anterior-posterior
position in the LPM determine the cell type and the position of liver, respectively. They cooperatively activate Wnt2bb signaling in the hepatic endoderm.
L, hepatic endoderm.
(W) In nonendodermal cells aroundWnt2bb, EpCAM is absent. Lrp6 forms an inhibitory ternary complex with Kremen1 and Dkk2. Thus, Lrp6 is removed from the
cell surface and Wnt2bb signaling is not licensed.
(X) In hepatic endodermal cells, EpCAM directly binds to Kremen1, which disrupts the Dkk2-Kremen1 interaction. This stabilizes Lrp6 on the endodermal cell
surface and allows formation of active Lrp6-signalosomes, licenses, and cooperatively activates Wnt2bb signaling for hepatic development.
See also Figures S1, S7, and Table S1.
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EpCAM Licenses Hepatic DevelopmentDeduced from our study, a possible role of EpCAM in chronic
liver diseases is that liver progenitor cells may require EpCAM
to license their differentiation to hepatocytes in response to
Wnt3a frommacrophage. Similar mechanismsmay also execute
in the development of other cellular systems such as lateral line
primordia in which Wnt and EpCAM are active (Villablanca et al.,
2006; Aman and Piotrowski, 2008). In hi2151 mutant embryos,
injection of epcam or epcam ECD mRNA could rescue dimin-
ished expressions of fgf3 and dkk1b (Figure S7), downstream
factors of Wnt signaling in the lateral line primordia.
In summary, our study addresses the molecule and mecha-
nism of how endodermal cells obtain the competence to respond
to the liver-inductive Wnt2bb signal (Figures 7V–7X), shedding
light on the cell-type-specific competence issues in develop-
mental biology (Zaret, 2008; Zorn and Wells, 2009; Wandzioch
and Zaret, 2009; van Amerongen and Nusse, 2009). In nonendo-
dermal cells around Wnt2bb, hepatic development is not550 Developmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevierlicensed due to the absence of EpCAM, so that Lrp6 on the
plasma membrane and formations of Lrp6-signalosomes are
insufficient. Wnt2bb ligand loses EpCAM to cooperatively acti-
vate the downstream signaling (Figure 7W). In endodermal cells,
EpCAM licenses hepatic development through stabilization of
Lrp6 on the cell surface thus allowing Lrp6 clustering into active
signalosomes, and cooperatively activates the liver-inductive
signaling with Wnt2bb (Figure 7X). EpCAM in the endoderm
and Wnt2bb at a specific anterior-posterior position in the
LPM, respectively, determine cell type and position of liver
development, then act synergistically (Figure 7V).EXPERIMENTAL PROCEDURES
Zebrafish Strains
Zebrafish (Danio rerio) of the AB genetic background, hi2151/epcam mutant
line, Tg(lfabp:GFP), Tg(gutGFP), Tg(sox17:GFP), Tg(hsp70l:kremen1-GFP),Inc.
Developmental Cell
EpCAM Licenses Hepatic Developmentand Tg(rasGFP) transgenic lines were raised and maintained under standard
laboratory conditions according to Institutional Animal Care and Use
Committee protocols.
Expression Plasmids, mRNAs, and Morpholinos
See Supplemental Experimental Procedures.
In Situ Hybridizations, Antibody Staining, and Imaging
Whole mount in situ hybridizations, fluorescent in situ hybridizations, and anti-
body stainings were carried out as previously described (Liu et al., 2009; Brend
andHolley, 2009), using the following antisense probes: hhex, prox1, cp, sePb,
epcam, dkk1a, dkk1b, dkk2, wnt2bb, pdx1, kremen1, foxa3, myca, lrp5, fgf3
(Ober et al., 2006; Glasgow and Tomarev, 1998; Kudoh et al., 2001; Shin
et al., 2011), or antibodies against H3P (Millipore) or against the ICD of EpCAM
(prepared by GenScript). In situ hybridized, antibody stained, Tg(gutGFP),
Tg(sox17:GFP), Tg(rasGFP), living Tg(lfabp:GFP), and Tg(hsp70l:kremen1-
GFP) zebrafish embryos were imaged as previously described (Huang et al.,
2011).
Mosaic Analyses
Donor embryos were injected with 2 ng rhodamine-dextran (10,000 molecular
weight, Invitrogen), and cells were transplanted to acceptor embryos at the 1k-
cell stage. All the donor and acceptor embryos were under the Tg(lfabp:GFP)
transgenic background.
XAV939 Treatments and Heat Shock
Embryos were treated at 14 hpf for 12 hr with 5 mM XAV939 (Sigma) (a 5 mM
stock of XAV939 in DMSO was diluted into 5 mM final concentration in egg
water) or 0.1% DMSO as control. Treated embryos were washed twice and
then incubated in egg water until observed at 102 hpf. Tg(hsp70l:kremen1-
GFP) embryos at 18 hpf were heat-shocked at 38C for 45 min.
Cell Sorting, RT-PCR, and Quantitative Real-Time PCR
Sixty to 100 Tg(sox17:GFP) transgenic embryos at 24 hpf or 52 hpf were
deyolked, beheaded, and dissociated in 0.25% Trypsin solution (0.25%
trypsin and 1 mM EDTA in PBS, pH 8.0) for 5 min. Dissociated cells were
collected by centrifugation at 300 3 g for 2 min, resuspended in 1 ml PBS,
and filtered using 40-mm Falcon cell strainers. Then, cells were sorted using
a Moflo XDP Fluorescence-Activated Cell Sorter (Beckman) and GFP-positive
cells were collected. Total RNAs were isolated from dissociated embryos or
sorted cells using the TriZol reagent (Invitrogen). First strand cDNA syntheses
were performed using OmniScript RT Kit (QIAGEN). PCRs to detect the
transcriptions of foxa3, kremen1, and otx2 were performed. Quantitative
PCRs were carried out for nr1h4, rp2, prox1, cp, lfabp, myca, angptl3, sePb,
serpinc1, uox, ggcx, hhex, foxa3, pdx1, ptf1a, preproinsulin, ifabp, and GFP
using the FastStart Universal SYBRGreenMaster (Roche), normalized by tran-
scriptions of b-actin. Primer sequences are available on request.
Coimmunoprecipitation and Competition Assays
For EpCAM-Kremen1 and EpCAM-Lrp6 coimmunoprecipitations, 1 mg
epcam-Myc, 1.2 mg kremen1-HA, and 2 mg Lrp6-HA plasmids were trans-
fected into HEK293T cells using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. For EpCAM-Wnt2bb coimmunoprecipita-
tion, cells were transfected with 2.5 mg epcam-Myc or mock DNA. Thirty-six
hours after transfection, cells were incubated with medium containing
Wnt2bb-HA for 1 hr on ice, washed twice with PBS, and crosslinked using
DTSSP (Pierce) according to the manufacturer’s instructions. For one compe-
tition assay, 2.5 mg kremen1-HA and 0.5/1.25/2.5 mg epcam-Myc were trans-
fected. Forty-eight hours after transfections, cells were incubated with
medium containing Dkk2-Flag for 1 hr on ice, washed twice with PBS, and
crosslinked using DTSSP (Pierce). For the other competition assay, 1 mg
epcam-Myc, 0.8 mg kremen1-HA, and 0.25/0.5/1 mg dkk2-Flag plasmids
were transfected and cells were incubated for 36–48 hr after transfections.
For all the coimmunoprecipitations and competition assays, cells were har-
vested and lysed in the lysis buffer (20 mM Tris-HCl, pH7.5, 137 mM NaCl,
10% glycerol, 2 mM EDTA, 0.5% Triton X-100, and freshly added Complete
Mini Protease Inhibitor Cocktail [Roche]). Total cell lysates were prepared by
centrifugation at 16,0003 g for 15 min at 4C and collections of supernatants.DeveloLysates were subjected to immunoprecipitation with anti-HA (Covance) or
anti-Myc antibodies (Millipore) using Dynabead Protein G (Invitrogen) accord-
ing to the manufacturer’s instructions. Coimmunoprecipitated proteins were
eluted in 23 SDS sample buffer (125 mM Tris, pH6.8, 20% glycerol, 0.02%
bromophenol blue, 2% b-mercaptoethanol, and 4% SDS), separated on
12% SDS-PAGE gels, and analyzed by immunoblotting using anti-HA
(Covance), anti-Myc (Millipore), or anti-Flag antibodies (Sigma).
For coimmunoprecipitation in zebrafish embryos, 800–1,000 deyolked
embryos at 18–24 hpf were harvested in 500 ml lysis buffer. Total cell lysates
were prepared as described above, subjected to immunoprecipitation with
anti-Kremen1 antibodies (prepared by Abmart) or a preimmune serum using
Dynabead Protein A (Invitrogen), and analyzed by immunoblotting using
anti-Kremen1 antibodies and antibodies against the ICD of EpCAM (prepared
by GenScript).
GST Pull-Down Assays
cDNAs encoding the extracellular plus intracellular domains of EpCAM (resi-
dues 19–261 plus 285–303) was subcloned into the pGEX-KG vector (GE
Healthcare). Recombinant proteins were produced in BL21 Rosetta (DE3)
Escherichia coli strain (Novagen). For GST pull-down assays, HEK293T
cell lysates containing Kremen1-HA, Bmpr1ba-HA, or Wnt2bb-HA were
prepared as described above, followed by incubation at 4C for 2 hr with
40 mg recombinant GST-EpCAM or GST-Gem protein immobilized on the
Glutathione Sepharose 4B (GE Healthcare) beads. Samples were washed
with a washing buffer (20 mM Tris, pH7.5, 150 mM NaCl, 1 mM EDTA, 0.1%
NP-40, and freshly added Complete Mini Protease Inhibitor Cocktail [Roche])
for four times, resuspended in 23 SDS sample buffer, fractionated in SDS-
PAGE gels, and analyzed by immunoblotting using anti-HA antibodies
(Covance).
Cell Surface Biotinylation
Conditioned medium containing Dkk2-Flag was prepared as previously
described (Zhang et al., 2008a). HEK293T cells in 6-well plates were trans-
fected with 2.5 mg lrp6-Myc, 0.1 mg kremen1-HA, together with 0.05/0.25 mg
epcam-HA or mock plasmids. Thirty-six hours after transfection, cells were
washed with culture medium and incubated with 2 ml conditioned medium
containing Dkk2-Flag at 37C for 1 hr. After several washes with cold PBS,
cells were surface biotinylated using 0.5 mg ml1 sulpho-NHS-LC-biotin
(Pierce) according to the manufacturer’s instructions. Cell lysates were
prepared and subjected to immunoprecipitation by anti-Myc antibodies
(Millipore) as described above, followed by SDS-PAGE gel analyses and
immunoblotting using anti-Myc antibodies or HRP-streptavidin (Pierce).
Pulse-Chase Experiments
HEK293T cells in 10-cm dishes were transfected with 4 mg lrp6-Myc, 4 mg
bmpr1ba-HA, 0.4 mg kremen1, together with 0.4 mg epcam or mock plasmids.
Thirty hours after transfection, cells were surface biotinylated using
0.5 mg ml1 Sulfo-NHS-LC-Biotin (Pierce) according to the manufacturer’s
instructions, and returned to the CO2 incubator allowing recovery from the
biotinylation procedure for 2 hr. Cells were washed with culture medium and
incubated with Dkk2-Flag or control conditioned medium for the indicated
period of time. After several washes with cold PBS, membrane proteins
were prepared and biotinylated proteins were precipitated by NeutrAvidin
Agarose resins (Thermo Scientific) according to the manufacturer’s instruc-
tions, followed by SDS-PAGE gel analyses and immunoblotting using anti-
Myc or anti-HA antibodies.
Sucrose Density-Gradient Centrifugations
Sucrose density-gradient centrifugations were carried out as previously
described (Liang et al., 2011). In brief, HEK293T cells in 10-cm dishes were
transfected with 2 mg mouse wnt3a, or 10 mg epcam, or mock DNA, or incu-
bated with Wnt3a-conditioned medium for 3 hr. We used 0.2 mg mouse
wnt3a, 1 mg epcam, and mock DNA for transfections as low concentrations.
Thirty-six hours after transfection, cells were washed with cold PBS and lysed
in an extraction buffer (30 mM Tris, pH 7.4, 140 mM NaCl, 1% Triton X-100,
25 mM sodium fluoride, 5 mM sodium orthovanadate, and a protease inhibitor
cocktail tablet [Roche]) for 30min. The lysate was centrifuged at 16,0003 g for
15 min at 4C, and the supernatant was layered on top of a 15%–40% sucrosepmental Cell 24, 543–553, March 11, 2013 ª2013 Elsevier Inc. 551
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EpCAM Licenses Hepatic Developmentgradient prepared in a buffer containing 30 mM Tris, pH 7.4, 140 mM NaCl,
0.02% Triton X-100, 25 mM sodium fluoride, 5 mM sodium orthovanadate,
and protease inhibitors. Ultracentrifugation was performed at 217,000 3 g
for 4 hr at 4C. Fractions were collected from the bottom of the tube,
separated on 10% SDS-PAGE gels, and analyzed by immunoblotting using
anti-LRP6 (Cell Signaling Technology) or anti-p1493-LRP6 antibodies (Liang
et al., 2011).
Cell Immunofluorescence Staining
For detection of endogenous aggregates containing Thr1493-phosphorylated
LRP6, HEK293T cells in Lab-Tek chamber slides (Nunc) were transfected with
50 ng mouse wnt3a, 0.2 mg Bmpr1ba-HA, 0.3 mg epcam-Myc or mock
plasmids, and incubated for 24 hr. Cells were washed with PBS, fixed, per-
meabilized, stained with anti-p1493-LRP6 together with anti-Myc or anti-HA
antibodies, and analyzed as previously described (Liang et al., 2011).
TOP-FLASH Wnt Reporter Assays
Wnt reporter assays were carried out in triplicate in 24-well plates using
HEK293T cells and Dual-Luciferase Reporter Assay System (Promega) as
described previously (Molenaar et al., 1996; Wu et al., 2000; Major et al.,
2007). In each well, 50 ng TOP-FLASH Wnt reporter plasmid and 1 ng
pCMV-Renilla reporter plasmid were transfected along with 20 ng kremen1-
HA, 2 ng dkk2-Flag, 20 ng human epcam, 10 ng or 50 ng epcam-HA, 0.2 mg
lrp6-Myc, 20 ngmouse frizzled8, 20 ngmousewnt1, or 20 ngwnt2bb. The total
amount of DNA used in eachwell was unifiedwithmock plasmids pcDNA3.1 or
pCS2. Western blottings were performed using anti-hEpCAM (Abcam) and
anti-a-Tubulin (Sigma) antibodies.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online at
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